Powder Diffraction

Papers
(The TQCC of Powder Diffraction is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
CRL optics and silicon drift detector for P06 Microprobe experiments at 35 keV12
A method for mapping submicron-scale crystallographic order/disorder applied to human tooth enamel10
The Diamond I13 full-field transmission X-ray microscope: a Zernike phase-contrast setup for material sciences6
Crystal structure of atorvastatin calcium trihydrate Form I (Lipitor®), (C33H34FN2O5)2Ca(H2O)36
Quantification of solid-state impurity with powder X-ray diffraction using laboratory source5
Crystal structure from laboratory X-ray powder diffraction data, DFT-D calculations, Hirshfeld surface analysis, and energy frameworks of a new polymorph of 1-benzothiophene-2-carboxylic acid5
Laboratory XANES to study vanadium species in vanadium redox flow batteries5
Use of a Be-dome holder for texture and strain characterization of Li metal thin films via sin2(ψ) methodology5
X-ray diffraction as a major tool for the analysis of PM2.5 and PM10 aerosols4
An alternative neutron diffractometer performance for strain/stress measurements4
Validation of XRD phase quantification using semi-synthetic data4
Certification of SRM 640f line position and line shape standard for powder diffraction4
Characterization of δ-KZnPO4 by X-ray powder diffraction3
Review of the direct derivation method: quantitative phase analysis with observed intensities and chemical composition data3
Synthesis and optical properties of single-crystalline SnS1−xSex nanobelts3
Total pattern analyses for non-crystalline materials3
Grazing incidence X-ray diffraction measurement of silver nanoparticles in metal-assisted etching of silicon3
Crystal structure of ceftriaxone sodium hemiheptahydrate, C18H16N8O7S3Na2(H2O)3.53
Crystal structure of cephalexin monohydrate, C16H17N3O4S(H2O)3
Best references for the QPA of Portland cement2
Crystal structure of 3-[(3,4-dinitro-1H-pyrazol-1-yl)-NNO-azoxy]-4-nitro-1,2,5-oxadiazole2
X-ray imaging of silicon die within fully packaged semiconductor devices2
Are the Naica giant crystals deteriorating because of human action?2
Crystal structure of donepezil hydrochloride form III, C24H29NO3⋅HCl2
Crystal structure of 3,3′-(E)-diazene-1,2-diylbis{4-[(3,4-dinitro-1H-pyrazol-1-yl)-NNO-azoxy]-1,2,5-oxadiazole}2
Crystal chemistry, X-ray diffraction reference patterns, and bandgap studies for (BaxSr1–x)2CoWO6 (x = 0.1, 0.2, 0.3, 0.5, 0.7, and 0.92
Convolution and deconvolutional treatment on sample transparency aberration in Bragg–Brentano geometry2
Crystal structure of levocetirizine dihydrochloride Form I, C21H27ClN2O3Cl22
Continuous series of symmetric peak profile functions determined by standard deviation and kurtosis2
Testing the flow-through capillary for the study of re-solvation processes in pharmaceutical compounds2
X-ray powder diffraction data of LaNi0.5Ti0.45Co0.05O3, LaNi0.45Co0.05Ti0.5O3, and LaNi0.5Ti0.5<2
Powder X-ray diffraction of escitalopram oxalate oxalic acid hydrate, (C20H21FN2O)2(C2O4)(H2C2O4)(H2
Crystal morphology prediction and experimental verification of venlafaxine hydrochloride2
ICDD® InSession: Mastering the PDF® Database and JADE® Software2
Temperature-dependent structure of an intermetallic ErPd2Si2 single crystal: a combined synchrotron and in-house X-ray diffraction study1
Crystal structure of (E)-doxepin hydrochloride, C19H22NOCl1
Crystal structure of meglumine diatrizoate, (C7H18NO5)(C11H8I3N2O4)1
Crystal structure of butenafine hydrochloride, C23H28NCl1
Powder X-ray diffraction of pazopanib hydrochloride Form 1, C21H24N7O2SCl1
Crystal structure and X-ray absorption spectroscopy of trimethylarsine oxide dihydrate, (CH3)3AsO⋅2H2O1
How to use and how not to use certified reference materials in industrial chemical metrology laboratories1
Crystal structure of danofloxacin mesylate (C19H21FN3O3)(CH3O3S)1
Crystal structure of strontium hydrogen citrate monohydrate, Sr(HC6H5O7)(H2O)1
Crystal structure of eltrombopag olamine Form I, (C2H8NO)2 (C25H20N4O4)1
Crystal structure of edoxaban tosylate monohydrate Form I, (C24H31ClN7O4S)(C7H7O3S)(H2O)1
In situ XRPD study of the ambient-pressure synthesis of nonstoichiometric Ag3O from Ag–Ag2O thin films: Phase abundance, unit-cell parameters, and c/a as a f1
Quantitative phase analysis of commercial ammonium phosphates by PXRD for application in biological systems1
Crystal structure from laboratory X-ray powder diffraction data, DFT-D calculations, and Hirshfeld surface analysis of (S)-dapoxetine hydrochloride1
Measurement of coating thickness with X-ray diffraction1
Low-temperature crystal structures of the solvent dimethyl carbonate1
Crystal structure of tamsulosin hydrochloride, C20H29N2O5SCl1
Refitting an X-ray diffraction system for combined GIXRF and XRR measurements1
Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl1
Crystallite size distribution by two-dimensional XRD1
Equatorial aberration for powder diffraction data collected by continuous-scan integration of a silicon strip X-ray detector1
Crystal structure and magnetic properties of ternary Al3CoNd2 compound1
X-ray powder diffraction data for tetrazene nitrate monohydrate, C2H9N11O4 – ADDENDUM1
Crystal structure of pomalidomide Form I, C13H11N3O41
Synthesis, powder diffraction pattern, crystal structure determination of the pharmaceutical co-crystal of levetiracetam and 3,5-dinitrosalicylic acid1
Powder X-ray structural analysis and bandgap measurements for (CaxSr2−x)MnWO6 (x = 0.25, 0.5, 0.75, 1.5, 1.75)1
Method of calculating the coherent scattering power of crystals with unknown atomic arrangements and its application in the quantitative phase analysis1
Method of calculating the coherent scattering power of crystals with unknown atomic arrangements and its application in the quantitative phase analysis — Addendum1
Application of deconvolutional treatment to powder diffraction data collected with a Bragg-Brentano diffractometer with a contaminated Cu target and a Ni filter1
Texture and strain analysis of tungsten films via Tilt-A-Whirl methodology1
Crystal structure of ivermectin hemihydrate ethanolate, (C48H74O14)(H2O)0.5(C2H5OH)0.821
Powder X-ray diffraction of daclatasvir dihydrochloride Form N-2 (Daklinza®), C40H52N8O6Cl21
0.042853116989136